INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 438m ago
HOUSE PTR38m ago
SEC 13F38m ago
ROBINHOOD CHAIN37m ago
Corporate insider
CP

Coyne Terrance P.

EVP & CFOCIK 0001814876

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells0 / 14
Max Insider Score24
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$541K
9,230 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Royalty Pharma plcEVP & CFO · Nov 7, 2025
18
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL
$105K
1,772 sh
Aug 13, 2026
Aug 17, 2026
traded Aug 13, 2026
+4d
SEC FORM 4

Evidence

5
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Gift
G—
18.5K sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC FORM 4

Evidence

2
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Grant or award
A—
11.0K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC FORM 4

Evidence

19
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$1.64M
32.9K sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC FORM 4

Evidence

1
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$93K
1,875 sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC FORM 4

Evidence

1
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$85K
1,875 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC FORM 4

Evidence

15
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$1.50M
32.9K sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC FORM 4

Evidence

14
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Grant or award
A—
26.6K sh
Feb 11, 2026Feb 13, 2026
traded Feb 11, 2026
+2dSEC FORM 4

Evidence

16
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$148K
3,750 sh
Jan 20, 2026Jan 23, 2026
traded Jan 20, 2026
+3dSEC FORM 4

Evidence

22
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$2.59M
65.8K sh
Jan 20, 2026Jan 23, 2026
traded Jan 20, 2026
+3dSEC FORM 4

Evidence

24
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$2.13M
55.1K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

18
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$121K
3,126 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

11
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$24K
624 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

17
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$406K
10.7K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

23
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$2.59M
65.8K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

17
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$147K
3,750 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

13
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Grant or award
A—
6,168 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC FORM 4

Evidence